3D AI Cancer Dx Platform (w/ PathNet)
Cancer Diagnostics
DevelopmentActive
Key Facts
About Alpenglow Biosciences
Alpenglow Biosciences is a private company pioneering 3D histology imaging and AI-powered digital pathology. Its Aurora 3D™ platform integrates proprietary hardware (3Di™ microscope), software (3Dm™ data management), and AI analytics (3Dai™) to generate spatial biology insights from whole, intact tissue specimens, moving beyond traditional 2D slide analysis. The company is revenue-generating through its platform and services, with a focus on applications in immuno-oncology, dermatology, and neuroscience, and has secured significant non-dilutive funding and key partnerships to advance its technology towards clinical diagnostics.
View full company profileTherapeutic Areas
Other Cancer Diagnostics Drugs
| Drug | Company | Phase |
|---|---|---|
| Isabl for Oncology | Isabi | Unknown |
| Aperio Digital Pathology Ecosystem | Leica Biosystems | Commercial & Development |
| Oncology Assay Development | Transformative Biotech | Research |
| Cell Separation for Liquid Biopsy | SynderBio | Pre-clinical |
| TelomeScan (OBP-401, OBP-1101) | Oncolys BioPharma | Diagnostic |